Matono T, Tada T, Hiraoka A, Hirooka M, et al. Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real-World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA Trial. J Gastroenterol Hepatol 2026 May 22. doi: 10.1111/jgh.70422.
PMID: 42175630